Lactic acidosis in sepsis: It's Not All anaerobic: Implications for diagnosis and management

Chest

Volumn 149, Issue 1, 2016, Pages 252-261

  Suetrong, Bandarn ^a   Walley, Keith R ^a  

^a ST PAUL S HOSPITAL   (Canada)

Author keywords

Cardiopulmonary resuscitation; Sepsis; Septic shock; Shock

Indexed keywords

ADENOSINE TRIPHOSPHATE; BICARBONATE; DICHLOROACETIC ACID; GLUCOSE; LACTIC ACID; PYRUVATE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE;

ACUTE LUNG INJURY; ANAEROBIC GLYCOLYSIS; DISEASE SEVERITY; GLUCOSE METABOLISM; HUMAN; HYPERLACTATEMIA; HYPOXEMIA; LACTATE BLOOD LEVEL; LACTIC ACIDOSIS; MONITORING; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PH; PHAGOCYTOSIS; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY CHAIN; REVIEW; SEPSIS; SEPTIC SHOCK; ACIDOSIS, LACTIC; COMPLICATION; METABOLISM;

ACIDOSIS, LACTIC; HUMANS; SEPSIS;

EID: 84954110681     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.15-1703     Document Type: Review

References (90)

1. Mizock BA, Falk JL. Lactic acidosis in critical illness. Crit Care Med. 1992;1(20):80-93.
2. Gladden LB. Lactate metabolism-A new paradigm for the third millennium. J Physiol. 2004;558:5-30.
3. Fuller BM, Dellinger RP. Lactate as a hemodynamic marker in the critically ill. Curr Opin Crit Care. 2012;18(3):267-272.
4. Kompanje EJ, Jansen TC, van der Hoven B, Bakker J. The first demonstration of lactic acid in human blood in shock by Johann Joseph Scherer (1814-1869) in January 1843. Intensive Care Med. 2007;33(11):1967-1971.
5. Huckabee WE. Abnormal resting blood lactate. I. The significance of hyperlactatemia in hospitalized patients. Am J Med. 1961;30: 833-839.
6. Huckabee WE. Abnormal resting blood lactate. II. Lactic acidosis. Am J Med. 1961;30:840-848.
7. Cohen RD, Woods HF. Clinical and Biochemical Aspects of Lactic Acidosis. Oxford, UK: Blackwell Scientific; 1976.
8. Brooks GA. Cell-cell and intracellular lactate shuttles. J Physiol. 2009;587(23):5591-5600.
9. Brooks GA. Intra-And extra-cellular lactate shuttles. Med Sci Sports Exerc. 2000;32(4):790-799.
10. Leverve XM, Mustafa I. Lactate: A key metabolite in the intercellular metabolic interplay. Crit Care. 2002;6(4):284-285.
11. Van Hall G. Lactate as a fuel for mitochondrial respiration. Acta Physiol Scand. 2000;168(4):643-656.
12. Levy B. Lactate and shock state: The metabolic view. Curr Opin Crit Care. 2006;12(4):315-321.
13. Kellum JA, Kramer DJ, Lee K, Mankad S, Bellomo R, Pinsky MR. Release of lactate by the lung in acute lung Injury. Chest. 1997; 111(5):1301-1305.
14. Iscra F, Gullo A, Biolo G. Bench-To-bedside review: lactate and the lung. Crit Care. 2002;6(4):327-329.
15. Borregaard N, Herlin T. Energy metabolism of human neutrophils during phagocytosis. J Clin Invest. 1982;70(3):550-557.
16. Bar-Even A, Flamholz A, Noor E, Milo R. Rethinking glycolysis: on the biochemical logic of metabolic pathways. Nat Chem Biol. 2012;8(6):509-517.
17. Stanley WC. Myocardial lactate metabolism during exercise. Med Sci Sports Exerc. 1991;23(8):920-924.
18. Kline JA, Thornton LR, Lopaschuk GD, Barbee RW, Watts JA. Lactate improves cardiac efficiency after hemorrhagic shock. Shock. 2000;14:215-221.
19. van Hall G, Stromstad M, Rasmussen P, et al. Blood lactate is an important energy source for the human brain. J Cerebr Blood Flow Metab. 2009;29:1121-1129.
20. Juneja D, Singh O, Dang R. Admission hyperlactatemia: causes, incidence, and impact on outcome of patients admitted in a general medical intensive care unit. J Crit Care. 2011;26(3):316-320.
21. Dugas AF, Mackenhauer J, Salciccioli JD, Cocchi MN, Gautam S, Donnino MW. Prevalence and characteristics of nonlactate and lactate expressors in septic shock. J Crit Care. 2012;27(4):344-350.
22. Casserly B, Phillips GS, Schorr C, et al. Lactate measurements in sepsis-induced tissue hypoperfusion: results from the Surviving Sepsis Campaign Database. Crit Care Med. 2015;43(3):567-573.
23. Ronco JJ, Fenwick JC, Tweeddale MG, et al. Identification of the critical oxygen delivery for anaerobic metabolism in critically ill septic and nonseptic humans. JAMA. 1993;270(14):1724-1730.
24. Astiz ME, Rackow EC, Falk JL, Kaufman BS, Weil MH. Oxygen delivery and consumption in patients with hyperdynamic septic shock. Crit Care Med. 1987;15:26-28.
25. Friedman G, De Backer D, Shahla M, Vincent JL. Oxygen supply dependency can characterize septic shock. Intensive Care Med. 1998;24(2):118-123.
26. Hayes MA, Timmins AC, Yau EH, Palazzo M, Hinds CJ, Watson D. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med. 1994;330(24):1717-1722.
27. Suistomaa M, Ruokonen E, Kari A, Takala J. Time-pattern of lactate and lactate to pyruvate ratio in the first 24 hours of intensive care emergency admissions. Shock. 2000;14(1):8-12.
28. Levy B, Sadoune LO, Gelot AM, Bollaert PE, Nabet P, Larcan A. Evolution of lactate/pyruvate and arterial ketone body ratios in the early course of catecholamine-Treated septic shock. Crit Care Med. 2000;28(1):114-119.
29. Gallet D, Goudable J, Vedrinne JM, Viale JP, Annat G. Increased lactate/pyruvate ratio with normal beta-hydroxybutyrate/acetoacetate ratio and lack of oxygen supply dependency in a patient with fatal septic shock. Intensive Care Med. 1997;23(1): 114-116.
30. Dugas MA, Proulx F, de Jaeger A, Lacroix J, Lambert M. Markers of tissue hypoperfusion in pediatric septic shock. Intensive Care Med. 2000;26(1):75-83.
31. Rimachi R, Bruzzi de Carvahlo F, et al. Lactate/pyruvate ratio as a marker of tissue hypoxia in circulatory and septic shock. Anaesth Intensive Care. 2012;40(3):427-432.
32. ProCESS Investigators, Yealy DM, Kellum JA, Huang DT, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014;370(18):1683-1693.
33. ARISE Investigators; ANZICS Clinical Trials Group, Peake SL, Delaney A, Bailey M, et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014;371(16):1496-1506.
34. Astiz ME, Rackow EC, Kaufman B, Falk JL, Weil MH. Relationship of oxygen delivery and mixed venous oxygenation to lactic acidosis in patients with sepsis and acute myocardial infarction. Crit Care Med. 1988;16(7):655-658.
35. Sair M, Etherington PJ, Peter Winlove C, Evans TW. Tissue oxygenation and perfusion in patients with systemic sepsis. Crit Care Med. 2001;29(7):1343-1349.
36. VanderMeer TJ, Wang H, Fink MP. Endotoxemia causes ileal mucosal acidosis in the absence of mucosal hypoxia in a normodynamic porcine model of septic shock. Crit Care Med. 1995;23(7):1217-1226.
37. Opdam H, Bellomo R. Oxygen consumption and lactate release by the lung after cardiopulmonary bypass and during septic shock. Crit Care Resusc. 2000;2(3):181-187.
38. Gore DC, Jahoor F, Hibbert JM, DeMaria EJ. Lactic acidosis during sepsis is related to increased pyruvate production, not deficits in tissue oxygen availability. Ann Surg. 1996;224(1):97-102.
39. Morelli A, Ertmer C, Westphal M, et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: A randomized clinical trial. JAMA. 2013;310(16): 1683-1691.
40. Schumacker PT, Samsel RW. Oxygen delivery and uptake by peripheral tissues: physiology and pathophysiology. Crit Care Clin. 1989;5(2):255-269.
41. Herbertson MJ, Werner HA, Russell JA, Iversen K, Walley KR. Myocardial oxygen extraction ratio is decreased during endotoxemia in pigs. J Appl Physiol (1985). 1995;79(2):479-486.
42. Walley KR. Heterogeneity of oxygen delivery impairs oxygen extraction by peripheral tissues: Theory. J Appl Physiol (1985). 1996;81(2):885-894.
43. Humer MF, Phang PT, Friesen BP, Allard MF, Goddard CM, Walley KR. Heterogeneity of gut capillary transit times and impaired gut oxygen extraction in endotoxemic pigs. J Appl Physiol (1985). 1996;81(2):895-904.
44. Bateman RM, Walley KR. Microvascular resuscitation as a therapeutic goal in severe sepsis. Crit Care. 2005;9(Suppl 4):S27-S32.
45. Kreymann G, Grosser S, Buggisch P, Gottschall C, Matthaei S, Greten H. Oxygen consumption and resting metabolic rate in sepsis, sepsis syndrome, and septic shock. Crit Care Med. 1993;21(7): 1012-1019.
46. McCarter FD, Nierman SR, James JH, et al. Role of skeletal muscle Na+-K+ ATPase activity in increased lactate production in sub-Acute sepsis. Life Sci. 2002;70(16):1875-1888.
47. Bundgaard H, Kjeldsen K, Suarez Krabbe K, et al. Endotoxemia stimulates skeletal muscle Na+-K+-ATPase and raises blood lactate under aerobic conditions in humans. Am J Physiol Heart Circ Physiol. 2003;284(3):H1028-H1034.
48. Levy B, Desebbe O, Montemont C, Gibot S. Increased aerobic glycolysis through beta2 stimulation is a common mechanism involved in lactate formation during shock states. Shock. 2008;30(4): 417-421.
49. Levy B, Gibot S, Franck P, Cravoisy A, Bollaert PE. Relation between muscle Na+K+ ATPase activity and raised lactate concentrations in septic shock: A prospective study. Lancet. 2005; 365(9462):871-875.
50. James JH, Fang CH, Schrantz SJ, Hasselgren PO, Paul RJ, Fischer JE. Linkage of aerobic glycolysis to sodium-potassium transport in rat skeletal muscle. Implications for increased muscle lactate production in sepsis. J Clin Invest. 1996;98(10):2388-2397.
51. James JH, Wagner KR, King JK, et al. Stimulation of both aerobic glycolysis and Na(+)-K(+)-ATPase activity in skeletal muscle by epinephrine or amylin. Am J Physiol. 1999;277:E176-E186.
52. Levraut J, Ciebiera JP, Chave S, et al. Mild hyperlactatemia in stable septic patients is due to impaired lactate clearance rather than overproduction. Am J Respir Crit Care Med. 1998;157:1021-1026.
53. Revelly JP, Tappy L, Martinez A, et al. Lactate and glucose metabolism in severe sepsis and cardiogenic shock. Crit Care Med. 2005;33(10):2235-2240.
54. Michaeli B, Martinez A, Revelly JP, et al. Effects of endotoxin on lactate metabolism in humans. Crit Care. 2012;16(4):R139.
55. Berkman M, Ufberg J, Nathanson LA, Shapiro NI. Anion gap as a screening tool for elevated lactate in patients with an increased risk of developing sepsis in the emergency department. J Emerg Med. 2009;36(4):391-394.
56. Iberti TJ, Leibowitz AB, Papadakos PJ, Fischer EP. Low sensitivity of the anion gap as a screen to detect hyperlactatemia in critically ill patients. Crit Care Med. 1990;18:275-277.
57. Kraut JA, Madias NE. Serum anion gap: its uses and limitations in clinical medicine. Clin J Am Soc Nephrol. 2007;2(1):162-174.
58. Gallagher EJ, Rodriguez K, Touger M. Agreement between peripheral venous and arterial lactate concentrations. Ann Emerg Med. 1997;29(4):479-483.
59. Noordally O, Vincent JL. Evaluation of a new, rapid lactate analyzer in critical care. Intensive Care Med. 1999;25(5):508-513.
60. Contenti J, Corraze H, Lemoël F, Levraut J. Effectiveness of arterial, venous, and capillary blood lactate as a sepsis triage tool in ED patients. Am J Emerg Med. 2015;33(2):167-172.
61. Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39(2):165-228.
62. Mato AR, Luger SM, Heitjan DF, et al. Elevation in serum lactate at the time of febrile neutropenia (FN) in hemodynamically-stable patients with hematologic malignancies (HM) is associated with the development of septic shock within 48 hours. Cancer Biol Ther. 2010;9(8):585-589.
63. Hernandez G, Bruhn A, Castro R, et al. Persistent sepsis-induced hypotension without hyperlactatemia: A distinct clinical and physiological profile within the spectrum of septic shock. Crit Care Res Pract. 2012;2012:536852.
64. Hernandez G, Castro R, Romero C, et al. Persistent sepsis-induced hypotension without hyperlactatemia: is it really septic shock?J Crit Care. 2011;26(4):435.e9-e14.
65. Tang Y, Choi J, Kim D, et al. Clinical predictors of adverse outcome in severe sepsis patients with lactate 2-4 mM admitted to the hospital. QJM. 2015;108(4):279-287.
66. Wacharasint P, Nakada TA, Boyd JH, Russell JA, Walley KR. Normal-range blood lactate concentration in septic shock is prognostic and predictive. Shock. 2012;38(1):4-10.
67. Jansen TC, van Bommel J, Schoonderbeek FJ, et al. Early lactateguided therapy in intensive care unit patients: A multicenter, openlabel, randomized controlled trial. Am J Respir Crit Care Med. 2010;182(6):752-761.
68. Dettmer M, Holthaus CV, Fuller BM. The impact of serial lactate monitoring on emergency department resuscitation interventions and clinical outcomes in severe sepsis and septic shock: An observational cohort study. Shock. 2015;43(1):55-61.
69. Omar S, Burchard AT, Lundgren AC, Mathivha LR, Dulhunty JM. The relationship between blood lactate and survival following the use of adrenaline in the treatment of septic shock. Anaesth Intensive Care. 2011;39(3):449-455.
70. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368-1377.
71. Arnold RC, Shapiro NI, Jones AE, et al. Multicenter study of early lactate clearance as a determinant of survival in patients with presumed sepsis. Shock. 2009;32(1):35-39.
72. Nguyen HB, Rivers EP, Knoblich BP, et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med. 2004;32(8):1637-1642.
73. Jones AE, Shapiro NI, Trzeciak S, Arnold RC, Claremont HA, Kline JA. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: A randomized clinical trial. JAMA. 2010;303(8):739-746.
74. Puskarich MA, Trzeciak S, Shapiro NI, et al. Prognostic value and agreement of achieving lactate clearance or central venous oxygen saturation goals during early sepsis resuscitation. Acad Emerg Med. 2012;19(3):252-258.
75. Boyd JH, Walley KR. The role of echocardiography in hemodynamic monitoring. Curr Opin Crit Care. 2009;15(3):239-243.
76. Griffee MJ, Merkel MJ, Wei KS. The role of echocardiography in hemodynamic assessment of septic shock. Crit Care Clin. 2010;26(2): 365-382.
77. Mallat J, Pepy F, Lemyze M, et al. Central venous-To-Arterial carbon dioxide partial pressure difference in early resuscitation from septic shock: A prospective observational study. Eur J Anaesthesiol. 2014; 31(7):371-380.
78. Du W, Liu DW, Wang XT, et al. Combining central venous-Toarterial partial pressure of carbon dioxide difference and central venous oxygen saturation to guide resuscitation in septic shock. J Crit Care. 2013;28(6):1110.e1-e5.
79. Vallée F, Vallet B, Mathe O, et al. Central venous-To-Arterial carbon dioxide difference: An additional target for goal-directed therapy in septic shock?Intensive Care Med. 2008;34(12):2218-2225.
80. Boerma EC, Mathura KR, van der Voort PH, Spronk PE, Ince C. Quantifying bedside-derived imaging of microcirculatory abnormalities in septic patients: A prospective validation study. Crit Care. 2005;9(6):R601-R606.
81. Spronk PE, Ince C, Gardien MJ, Mathura KR, Oudemans-van Straaten HM, Zandstra DF. Nitroglycerin in septic shock after intravascular volume resuscitation. Lancet. 2002;360(9343):1395-1396.
82. Hoffmann JN, Vollmar B, Laschke MW, et al. Microhemodynamic and cellular mechanisms of activated protein C action during endotoxemia. Crit Care Med. 2004;32(4):1011-1017.
83. Myburgh JA, Higgins A, Jovanovska A, Lipman J, Ramakrishnan N, Santamaria J, and the CAT Study Investigators. A comparison of epinephrine and norepinephrine in critically ill patients. Intens Care Med. 2008;34(12):2226-2234.
84. Annane D, Vignon P, Renault A, et al; CATS Study Group. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: A randomised trial. Lancet. 2007;370(9588):676-684.
85. De Backer D, Biston P, Devriendt J, et al; SOAP II Investigators. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362(9):779-789.
86. Russell JA, Walley KR, Singer J, et al; VASST Investigators. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358(9):877-887.
87. Berg KM, Gautam S, Salciccioli JD, Giberson T, Saindon B, Donnino MW. Intravenous thiamine is associated with increased oxygen consumption in critically ill patients with preserved cardiac index. Ann Am Thorac Soc. 2014;11(10):1597-1601.
88. Cooper DJ, Walley KR, Wiggs BR, Russell JA. Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis. A prospective, controlled clinical study. Ann Intern Med. 1990;112(7):492-498.
89. De Corte W, Vuylsteke S, De Waele JJ, et al. Severe lactic acidosis in critically ill patients with acute kidney injury treated with renal replacement therapy. J Crit Care. 2014;29(4):650-655.
90. Stacpoole PW, Wright EC, Baumgartner TG, et al. A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults. The Dichloroacetate-Lactic Acidosis Study Group. N Engl J Med. 1992;327(22):1564-1569.